These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 19715837)

  • 41. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
    Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
    Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preliminary results of treatment with pegylated interferon alpha 2A for chronic hepatitis C virus in kidney transplant candidates on hemodialysis.
    Casanovas-Taltavull T; Baliellas C; Llobet M; Cruzado JM; Castellote J; Casanova A; Niubó J; Valls C; Serrano T
    Transplant Proc; 2007 Sep; 39(7):2125-7. PubMed ID: 17889113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit.
    Covic A; Maftei ID; Mardare NG; Ioniţă-Radu F; Totolici C; Tuţă L; Golea O; Covic M; Volovăţ C; Gusbeth-Tatomir P; Mircescu G
    J Nephrol; 2006; 19(6):794-801. PubMed ID: 17173254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of chronic hepatitis C in hemodialysis patients.
    Berenguer M
    Hepatology; 2008 Nov; 48(5):1690-9. PubMed ID: 18972442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of hepatitis C virus treatment in patients on hemodialysis: data from published meta-analyses in 2008.
    Casanovas Taltavull T; Baliellas Comellas C; Cruzado Garrit JM
    Transplant Proc; 2009; 41(6):2082-4. PubMed ID: 19715837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of chronic hepatitis C virus infection in hemodialysis patients].
    Kaya S
    Mikrobiyol Bul; 2008 Jul; 42(3):525-34. PubMed ID: 18822900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling hepatitis C virus therapies combining drugs and lectin affinity plasmapheresis.
    Tullis RH; Duffin RP; Ichim TE; Joyce JA; Levin NW
    Blood Purif; 2010; 29(2):210-5. PubMed ID: 20093829
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.